Evidence map›Paper›PMID 25336654›Full record

ReviewThe Journal of biological chemistry2014

O-GlcNAc and the epigenetic regulation of gene expression.

Brian A Lewis, John A Hanover

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 147 citations in OpenAlex.

  1. PerturbingCells · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. O-GlcNAcylation locks the m6A-SRSF1-MCL1 axis in myeloid malignancies.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. HumanResearch square · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. The O-GlcNAc dichotomy: when does adaptation become pathological?Clinical science (London, England : 1979) · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. MYC: a complex problem.Trends in cell biology · 2023
    Review
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Brian A LewisFrom the NCI and lewisbri@mail.nih.gov.
John A HanoverNIDDK, National Institutes of Health, Bethesda, Maryland 20892 jah@helix.nih.gov.
National Institutes of Health · USNeuroCognitive Institute · US

Funding

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of DiseaseZIADK060101 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$25.7M
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegenerationZIADK060103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$20.8M
Calmodulin-driven Nuclear Trafficking linked to diabetes and insulin signalingZIADK060102 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$8.5M
Regulation of Transcription Initiation and Elongation by O-GlcNAcylation EnzymesZIABC011223 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEWIS, BRIAN · 2009 to 2016
$3.8M
Intramural NIH HHS
6 · The paper itself

Abstract

O-GlcNAcylation is an abundant nutrient-driven modification linked to cellular signaling and regulation of gene expression. Utilizing precursors derived from metabolic flux, O-GlcNAc functions as a homeostatic regulator. The enzymes of O-GlcNAc cycling, OGT and O-GlcNAcase, act in mitochondria, the cytoplasm, and the nucleus in association with epigenetic "writers" and "erasers" of the histone code. Both O-GlcNAc and O-phosphate modify repeats within the RNA polymerase II C-terminal domain (CTD). By communicating with the histone and CTD codes, O-GlcNAc cycling provides a link between cellular metabolic status and the epigenetic machinery. Thus, O-GlcNAcylation is poised to influence trans-generational epigenetic inheritance.

Indexed as

Epigenesis, GeneticAcetylglucosamineAnimalsbeta-N-AcetylhexosaminidasesHistonesHumansN-AcetylglucosaminyltransferasesRNA Polymerase IIAcetylglucosaminebeta-N-Acetylhexosaminidaseshexosaminidase CHistonesN-AcetylglucosaminyltransferasesRNA Polymerase IIEpigeneticsGlycobiologyHistonesO-GlcNAcO-GlcNAcylationPolycombRNA Polymerase IISignalingTranscription

Identifiers

PMID25336654
PMCPMC4263851
OpenAlexW1975518025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.